学术探索
学术期刊
新闻热点
数据分析
智能评审

Diagnosis and treatment of antibody-mediated kidney allograft rejection

被引：47
作者：
Böhmig, G
Regele, H
机构：
[1] Univ Vienna, AKH, Clin Inst Pathol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria
来源：
TRANSPLANT INTERNATIONAL | 2003年 / 16卷 / 11期
关键词：
antibody-mediated rejection; apheresis; C4d; immunoadsorption; kidney; transplantation;
D O I：
10.1111/j.1432-2277.2003.tb00241.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Evidence of a significant pathogenetic role of donor-reactive antibodies (DRA) in kidney allograft rejection is accumulating. At least, partially owing to the recent discovery of the complement split product C4d as a valuable rejection marker, antibody-mediated rejection (AMR) has regained increasing attention. We review here the value of various diagnostic criteria, including immunohistochemistry (C4d staining), histomorphology and posttransplant serology, for the diagnosis of AMR. Furthermore, the mechanisms underlying alloantibody/complement-mediated allograft injury are discussed in detail. Finally, a thorough discussion of recently proposed "anti-humoral" therapeutic strategies is provided.
引用
收藏
页码：773 / 787
页数：15
相关论文
共 121 条
  • [1] Postoperative production of anti-donor antibody and chronic rejection in renal transplantation
    Abe, M
    Kawai, T
    Futatsuyama, K
    Tanabe, K
    Fuchinoue, S
    Teraoka, S
    Toma, H
    Ota, K
    [J]. TRANSPLANTATION, 1997, 63 (11) : 1616 - 1619
  • [2] Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation
    Abou el Fettouh, H
    Cook, DJ
    Bishay, E
    Flechner, S
    Goldfarb, D
    Modlin, C
    Dennis, V
    Novick, AC
    [J]. UROLOGY, 2000, 56 (03) : 369 - 372
  • [3] Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient
    Al-Uzri, A
    Seltz, B
    Yorgin, PD
    Spier, CM
    Andreoni, K
    [J]. PEDIATRIC TRANSPLANTATION, 2002, 6 (02) : 161 - 165
  • [4] Plasmapheresis in HLA-immunosensitized patients prior to kidney transplantation
    Alarabi, A
    Backman, U
    Wikstrom, B
    Sjoberg, O
    Tufveson, G
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1997, 20 (01) : 51 - 56
  • [5] ALLEN N, 1983, TRANSPLANT P, V15, P1060
  • [6] Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons:: depletion of CD20-and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody
    Alwayn, IPJ
    Xu, YX
    Basker, M
    Wu, C
    Buhler, L
    Lambrigts, D
    Treter, S
    Harper, D
    Kitamura, H
    Vitetta, ES
    Abraham, S
    Awwad, M
    White-Scharf, ME
    Sachs, DH
    Thall, A
    Cooper, DKC
    [J]. XENOTRANSPLANTATION, 2001, 8 (03) : 157 - 171
  • [7] Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: A case report
    Aranda, JM
    Scornik, JC
    Normann, SJ
    Lottenberg, R
    Schofield, RS
    Pauly, DF
    Miles, M
    Hill, JA
    Sleasman, JW
    Skoda-Smith, S
    [J]. TRANSPLANTATION, 2002, 73 (06) : 907 - 910
  • [8] Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes
    Baldwin, WM
    Samaniego-Picota, M
    Kasper, EK
    Clark, AM
    Czader, M
    Rohde, C
    Zachary, AA
    Sanfilippo, F
    Hruban, RH
    [J]. TRANSPLANTATION, 1999, 68 (06) : 894 - 900
  • [9] BALDWIN WM, 2000, TRANSPLANT REV, V14, P41
  • [10] BALDWIN WM, 1998, KIDNEY TRANSPLANT RE, P127
12345678910